Hormone Receptor Negative Breast Carcinoma
Also known as: Hormone Receptor-Negative Breast Carcinoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB17573 | Evorpacept | 1 | Recruiting | 1 |
| DB01229 | Paclitaxel | 1 | Withdrawn | 1 |
| DB14962 | Trastuzumab deruxtecan | 1 | Recruiting | 1 |
| DB16342 | Trastuzumab duocarmazine | 1 | Withdrawn | 1 |
| DB11652 | Tucatinib | 1 | Recruiting | 1 |
| DB15471 | Zanidatamab | 1 | Recruiting | 1 |
| DB15110 | Onvansertib | 1 / 2 | Recruiting | 1 |
| DB01229 | Paclitaxel | 1 / 2 | Recruiting | 1 |
| DB12001 | Abemaciclib | 2 | Recruiting | 1 |
| DB01217 | Anastrozole | 2 | Recruiting | 1 |
| DB06699 | Degarelix | 2 | Recruiting | 1 |
| DB00675 | Tamoxifen | 2 | Recruiting | 1 |